European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Grant programme · United States

National Center for Immunization and Respiratory Diseases

National Center for Immunization and Respiratory Diseases (United States): 38 grants in the last 24 months to 18 recipients; a typical grant is about €1,100,000. It funds most often: Research and development projects and Feasibility studies and proof of concept. Data as of 17 November 2026; updated daily.

Grants in the last 24 months
38
Recipients
18
Total, last 24 months
≈ €38,000,000
Typical grant (median)
≈ €1,100,000
Open calls
0
Calls on the site
0

Open calls

No records yet.

Latest grants

ProjectRecipientGrantDate
RFA-IP-22-004, Multidisciplinary Approach to Understanding Vaccine Efficacy and Transmission of Viral Respiratory Tract Infections in the Real WorldWASHINGTON UNIVERSITY€1,346,30430 September 2026
Optimized Zanamivir MicroArray Patch (MAP) Formulation for Single Application Treatment of the FluTSRL, INC.€260,23530 September 2026
RFA-IP-22-004, Evaluating influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness in prevention of acute illness in Washington state 2022-2027KAISER FOUNDATION HEALTH PLAN OF WASHINGTON€1,143,63430 September 2026
RFA-IP-22-004, Platform to Assess Influenza and COVID-19 Vaccine Effectiveness in Underserved Arizona PopulationsARIZONA STATE UNIVERSITY-TEMPE CAMPUS€1,346,30430 September 2026
RFA-IP-22-004, CORVETS - Cleveland Ohio Respiratory Viruses Vaccines Effectiveness across Traditional Risk Factors and Social Determinants of HealthUNIVERSITY HOSPITALS OF CLEVELAND€912,01330 September 2026
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare systemUNIVERSITY OF PITTSBURGH AT PITTSBURGH€1,085,72930 September 2026
RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).BAYLOR RESEARCH INSTITUTE€1,143,63430 September 2026
RFA-IP-22-001 - Burden and sequelae of influenza, SARS-CoV-2 and other respiratory viruses associated Severe Acute Respiratory Infections among Indian adult population aged 18-60yrsALL-INDIA INSTITUTE OF MEDICAL SCIENCES€434,29230 September 2026
RFA-IP-22-004:Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus VaccinesUNIVERSITY OF MICHIGAN AT ANN ARBOR€1,143,63430 September 2026
RFA-IP-24-046: Nationwide Cohort of Blood Donors to Estimate Burden of Respiratory Viruses and Immunologic ResponseVITALANT€1,302,8751 September 2026

Most grants went to

  1. University of Pittsburgh at Pittsburgh 4
  2. University of Michigan at Ann Arbor 4
  3. University Hospitals of Cleveland 3
  4. Beth Israel Deaconess Medical Center 2
  5. Arizona State University-Tempe Campus 2
  6. Washington University 2
  7. Seattle Children'S Hospital 2
  8. Kaiser Foundation Health Plan of Washington 2
  9. Baylor Research Institute 2
  10. Cincinnati Childrens Hosp Med CTR 2

What the money buys

Who it is for

Grant calendars

Grants for projects that started between 17 November 2024 and 17 November 2026; amounts in euro at the Eurostat rate of each year.

Questions and answers

When does National Center for Immunization and Respiratory Diseases open calls?
No call is open right now.
How much is a grant from National Center for Immunization and Respiratory Diseases?
In the last 24 months the median grant was about €1,100,000; 38 grants, about €38,000,000 in all.
Who gets grants from National Center for Immunization and Respiratory Diseases?
Most grants in the last 24 months: UNIVERSITY OF PITTSBURGH AT PITTSBURGH (4), UNIVERSITY OF MICHIGAN AT ANN ARBOR (4) and UNIVERSITY HOSPITALS OF CLEVELAND (3).
What does National Center for Immunization and Respiratory Diseases fund?
Most often: Research and development projects and Feasibility studies and proof of concept.